Saint Barnabas insulin-poisoning campaign

The Saint Barnabas insulin-poisoning campaign was a series of deliberate IV-bag tamperings that turned ordinary treatment into a hidden source of danger. The hospital found insulin in bags meant for other therapies and traced a pattern of severe patient crashes across several units. Its internal inquiry focused on nurse Charles Cullen, but uncertainty, fragmented records, and the difficulty of matching his irregular shifts to each incident kept suspicion from becoming proof. The episodes ceased after he left the hospital; their consequences, including heightened scrutiny of insulin and unease among staff, persisted.

Discovery and the first patient crises

On February 11, 1991, pharmacy nurse Pam Allen brought a suspicious IV bag to risk manager Karen Seiden. Its port appeared used, even though the bag was full enough to leak. Seiden involved assistant security director Thomas Arnold, a former police officer, who sent the bag to the pathology lab. It was supposed to contain saline and heparin; testing found insulin as well. At that point, the bag was evidence of tampering, but the inquiry had not yet established how many patients might be at risk.

Three days later, Anna Byers, a Critical Care Unit patient, began receiving heparin. Within half an hour she was sweating, confused, nauseated, and weak. Her insulin level was extraordinarily high. Orange juice did not correct the crisis, and intravenous dextrose only temporarily countered it. When her heparin drip was removed before a planned heart catheterization, the symptoms eased. Back in her room and stable, she was put on heparin again; the crash returned. By late evening her blood sugar was too low to measure, and she was close to coding. Her nurses rushed her to intensive care, but within twenty minutes off the drip she felt better. The repeated connection between the heparin infusion and her deterioration made an ordinary medication problem increasingly difficult to explain.

Fred Belf, in another part of the hospital, experienced a similar pattern. After his heparin began, he vomited and could not keep down orange juice; he received dextrose alongside the heparin, with his condition fluctuating through the day and night. When nurses disconnected the heparin, he quickly improved. They sealed his IV bag in sterile plastic and sent it for testing. The result was positive for insulin. Microscopic examination showed tiny needle punctures across the bag, including three along its edges. Such punctures did not fit the usual process of connecting an IV bag to a stopcock, and their placement suggested repeated, intentional interference rather than an accidental needle stick.

Pattern, suspicion, and the limits of proof

Arnold and Seiden searched Critical Care Unit records for other unexplained insulin crashes. They found that patients had been collapsing regularly for months, with emergency codes sometimes overlapping. The incidents crossed intensive care, critical care, and cardiac units, and did not fall neatly into a single shift or ward. Laboratory testing showed exceptionally high levels of insulin, much of it foreign to the patients’ bodies: it had been administered to them.

The first working explanation was an ordinary medication error, such as a misread order or mislabeled vial. But chart reviews found no physician order for insulin and no nursing notation that it had been given. That left either an undocumented double error or deliberate administration. Arnold brought the findings to Joe Barry, Saint Barnabas Medical Center’s security chief and senior vice president, a former thirty-year police veteran. After they ruled out patients’ visitors, Arnold and Barry compared nursing schedules with the times of the codes. Three nurses had been working every code; Charles Cullen drew particular attention.

Cullen’s demeanor sharpened the investigators’ concern but did not itself establish guilt. Other staff members appeared anxious about their patients and reputations; Cullen, by contrast, seemed unconcerned and defiant. Because he worked through a staffing service and his shifts varied, Arnold had difficulty arranging an interview. When Cullen finally sat down with Arnold and Barry, he refused to answer questions. The investigators found his silence disturbing, but understood that their case had to rest on evidence rather than attitude.

That evidence remained inconclusive. Cullen floated among units and sometimes came in on unscheduled calls, making it difficult to align his presence with individual patients’ crashes. Those patients had complex illnesses, and their deteriorations could not always be tied to one event or to their eventual deaths. The growing collection of questionable cases therefore did not give Arnold and Barry the direct, case-making certainty they needed. Their own attempts to reconstruct timelines and mortality patterns exposed more anomalies without resolving that central gap.

Investigation, departure, and aftermath

Arnold and Barry sought outside help from Livingston police chief Don Jones, but he declined to take on the investigation, advising the hospital to handle the matter internally. The decision left the problem with the hospital, which continued its inquiry. Arnold and Barry installed stop-motion cameras in the medication-storage room, interviewed physicians, staff, and families, and introduced a drug sign-out protocol that subjected insulin to controls like those used for morphine. These measures reflected the seriousness of the suspected tampering, but they did not catch Cullen in the act or produce proof sufficient to resolve the case.

In October, two more Saint Barnabas Critical Care Unit patients suffered unexplained hypoglycemia and were found connected to insulin-tainted IV bags. The new incidents strengthened the investigators’ suspicions, but not their ability to prove who was responsible. Then Cullen left the hospital. The insulin spikes stopped with his departure, a consequential change that aligned the end of the incidents with the disappearance of their leading suspect, even though the inquiry had not established the connection in a form that could settle the matter.

The episode also changed how insulin was handled and how staff understood hospital procedure. Amy Loughren, an ICU nurse, was asked to sign an insulin adjustment form recording her estimate of how much remained in a vial. She objected that the estimate was unreliable and that nurses were being held accountable without being told why insulin had suddenly acquired controls associated with narcotics. Her refusal brought her into conflict with her manager, while the unexplained rule signaled that something serious had happened on the unit. Later, amid police interviews and hospital rumors, Amy’s friendship with Cullen became another source of pressure: colleagues knew she had defended him and had challenged the insulin protocol, and some began avoiding her. The campaign thus left more than evidence of contaminated bags. It created a lasting conflict between patient-safety measures and the secrecy surrounding the reasons for them.